Supplier News Breaks Archives
CutisPharma Inc. has extended its FIRST Magic Mouthwash line with four- and six-ounce BLM compounding kits.
Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength.
PuraMed BioScience Inc. is hatching plans for the national product launch of LipiGesic M, its clinically tested migraine headache treatment.
Prestige Brands Holdings Inc. plans to acquire 17 over-the-counter pharmaceutical brands sold in North America from GlaxoSmithKline in $660 million cash deal.
Amgen and Watson Pharmaceuticals Inc. plan to collaborate on the development and global commercialization of several oncology antibody biosimilar medicines.